Contributors

Contributors By the time Guillermina Girardi earned her PhD from the Universidad Nacional de Rosario in Argentina in 1994, she never got the opportunity to study abroad. So when the chance came up to do a two-year training program at the Hospital for Special Surgery, an affiliate of Weill Cornell Medical College in New York, in December of 2000, she jumped on it. She ultimately worked as an assistant professor of pharmac

Written byThe Scientist
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

By the time Guillermina Girardi earned her PhD from the Universidad Nacional de Rosario in Argentina in 1994, she never got the opportunity to study abroad. So when the chance came up to do a two-year training program at the Hospital for Special Surgery, an affiliate of Weill Cornell Medical College in New York, in December of 2000, she jumped on it. She ultimately worked as an assistant professor of pharmacology and toxicology at Cornell studying pregnancy complications. "It was heartbreaking because there's nothing you can do for [women]." But as she discusses in Safeguarding the Foreigner Within, she has recently unearthed a possible solution: a drug previously marketed for cardiovascular disease. "These women deserve some hope."

Les Costello has spent most of his academic career at the University of Maryland. Now a professor of physiology and endocrinology at the Dental School in Baltimore, he has been conducting research on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies